FHA
ONC

Flagship Harbor Advisors’s BeOne Medicines Ltd ONC Stock Holding History

Flagship Harbor Advisors’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-150
Closed -$42K – 1831
2020
Q3 		$42K Hold
150
– – 0.01% 908
2020
Q2 		$28K Sell
150
-250
-63% -$40.7K ﹤0.01% 1036
2020
Q1 		$49K Sell
400
-75
-16% -$11.7K 0.01% 758
2019
Q4 		$79K Hold
475
– – 0.01% 687
2019
Q3 		$58K Buy
+475
New +$63.1K 0.01% 739

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Flagship Harbor Advisors's ONC Position: Q4 2020 in Review

Flagship Harbor Advisors sold out of BeOne Medicines Ltd (ONC) in Q4 2020, closing a stake of 150 shares — an estimated $42K sold.

Flagship Harbor Advisors first reported a position in ONC in Q3 2019 and held it in 5 quarters. The position peaked at $79K in Q4 2019. 248 funds tracked by Wall St. Rank hold ONC as of Q4 2020.

  • Flagship Harbor Advisors reported no remaining BeOne Medicines Ltd position as of Q4 2020 after selling out during the quarter.
  • Flagship Harbor Advisors sold 150 BeOne Medicines Ltd shares in Q4 2020, an estimated $42K.
  • Flagship Harbor Advisors first reported a position in BeOne Medicines Ltd in Q3 2019 and held it in 5 quarters.
  • Flagship Harbor Advisors's BeOne Medicines Ltd position peaked at $79K in Q4 2019.
  • 248 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2020.

Based on Flagship Harbor Advisors's 13F filing for Q4 2020, filed 8 Feb 2021.